Skip to main content
Clinical Trials/NCT02513212
NCT02513212CompletedNot Applicable

A Clinical Study to Determine the Safety and Effectiveness of Dentinal Hypersensitivity Treatment With Two Different Toothbrushes

Procter and Gamble1 site in 1 country24 target enrollmentStarted: July 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
24
Locations
1
Primary Endpoint
Change From Baseline Air Challenge

Study Overview

Brief Summary

This study will determine the effects toothbrush type (power or manual) has on the safety and effectiveness of professional dentinal hypersensitivity treatment with a marketed oxalate-containing solution.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • be at least 18 years of age;
  • provide written informed consent prior to participation and be given a signed copy of the informed consent form;
  • complete a photography consent agreement pertaining to the collection and use of non-identifying intraoral photographs;
  • be in good general health as determined by the Investigator/designee; and
  • have at least one tooth with a Schiff sensitivity score of at least 1 in response to the cool air challenge.

Exclusion Criteria

  • self-reported pregnancy or nursing;
  • severe periodontal disease, as characterized by purulent exudate, generalized mobility, and/or severe recession;
  • active treatment of periodontitis;
  • any diseases or conditions that might interfere with the safe completion of the study; or
  • an inability to undergo any study procedures.

Arms & Interventions

oxalate liquid, SnF2 paste, manual toothbrush

Other

Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Manual toothbrush

Intervention: Potassium Oxalate (Device)

oxalate liquid, SnF2 paste, manual toothbrush

Other

Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Manual toothbrush

Intervention: Stannous fluoride paste (Drug)

oxalate liquid, SnF2 paste, manual toothbrush

Other

Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Manual toothbrush

Intervention: Manual toothbrush (Device)

oxalate liquid, SnF2 paste, power toothbrush

Other

Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Power toothbrush

Intervention: Potassium Oxalate (Device)

oxalate liquid, SnF2 paste, power toothbrush

Other

Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Power toothbrush

Intervention: Stannous fluoride paste (Drug)

oxalate liquid, SnF2 paste, power toothbrush

Other

Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Power toothbrush

Intervention: Power toothbrush (Device)

Outcomes

Primary Outcomes

Change From Baseline Air Challenge

Time Frame: 30 days

The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows- 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subject responds to stimulus and requests discontinuation or moves form stimulus, 3: tooth/subject responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. The higher the Schiff score, the more sensitive the tooth. The mean change from Baseline was calculated for this measure.

Secondary Outcomes

  • Change From Baseline Visual Analog Scale(30 days)

Investigators

Sponsor
Procter and Gamble
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

A Clinical Study to Determine the Safety... | Clinical Trial